UK and EU Food Supplement Compliance: Technical Standards for Formulators and Brand Owners

## Regulatory Baselines: FSA and EFSA Divergence Following the UK’s formal withdrawal from the European Union, food supplement brand owners, formulators, and contract manufacturers operate within an increasingly divergent regulatory landscape. In Great Britain (GB), the Food Standards Agency (FSA) and Food Standards Scotland (FSS) govern food safety and composition via assimilated EU legislation alongside domestic statutes, including the Food Supplements (England) Regulations 2003 and equivalent statutory instruments in the devolved administrations. Under the Windsor Framework, Northern Ireland continues to adhere directly to the EU single-market acquis. Conversely, the European Food Safety Authority (EFSA) and the European Commission oversee nutritional governance across the EU under Directive 2002/46/EC. While initial statutory baselines for vitamins, minerals, and positive ingredient lists shared common origin, independent risk assessments, diverging novel food authorisations, and disparate national-level maximum permitted levels (MPLs) across EU member states now require jurisdictional auditing. Formulators cannot assume mutual recognition or cross-border regulatory parity between GB and EU markets. ## Good Manufacturing Practice and Traceability Standards Manufacturing integrity within the nutraceutical and food supplement sector relies on strict adherence to Good Manufacturing Practice (GMP) principles and Hazard Analysis Critical Control Point (HACCP) frameworks. For contract manufacturers, maintaining accredited quality management systems—such as BRCGS (Brand Reputation Compliance Global Standard) Food Safety, ISO 22000, or FSSC 22000 certifications—is essential to mitigate chemical, physical, and microbiological contamination risks. Traceability remains a central metric during regulatory inspections and third-party audits. Under UK General Food Law (Regulation (EC) No 178/2002, as assimilated) and corresponding EU law, food business operators (FBOs) must maintain documented one-step-forward, one-step-back traceability across the entire supply chain. This mandate extends from the source provenance of raw botanical extracts and active substances through to primary packaging materials. Validated Batch Manufacturing Records (BMRs), analytical Certificates of Analysis (CoAs), and stability testing protocols are mandatory to verify ingredient safety, nutrient retention, and declared shelf-life parameters. ## Health Claims Substantiation and Labelling Protocols Commercial communications and on-pack claims are strictly governed by Regulation (EC) No 1924/2006, mirrored in GB law through the Great Britain Nutrition and Health Claims Register. Permitted claims are restricted to authorised entries; medicinal, therapeutic, or disease-prevention claims remain strictly prohibited for food supplements in both jurisdictions. For commercial teams and brand owners, label compliance demands absolute alignment between declared active dosages and the statutory conditions of use linked to authorised claims. Micronutrient claims, for instance, typically require the finished product to satisfy the criteria for a "significant source"—defined as a minimum of 15% of the Nutrient Reference Value (NRV) per daily recommended dose. Departing from authorised claim wording or marketing non-substantiated active ingredients introduces material risk of local authority enforcement, Advertising Standards Authority (ASA) interventions, or mandatory product recalls. ## Novel Foods and Raw Material Verification Verification of novel food status represents a further compliance hurdle. Any substance or botanical extract lacking a documented history of significant consumption within the UK or EU prior to 15 May 1997 falls within the scope of the Novel Food Regulations (Regulation (EU) 2015/2283, as assimilated in GB). Unauthorised novel foods cannot lawfully be placed on the market until a full safety and toxicological dossier has been evaluated and approved by the respective authority (the FSA/FSS in GB, or EFSA and the European Commission in the EU). Formulators and brand owners must conduct documented due diligence on all imported raw materials, active isolates, and fermentation-derived substances. Quality assurance workflows must incorporate verified compositional analysis, heavy metal assays (lead, cadmium, mercury, and arsenic), solvent residue testing, and pesticide multi-residue screens benchmarked against relevant pharmacopoeial standards and statutory maximum residue limits.